ACADIAN ASSET MANAGEMENT LLC - CHINA SXT PHARMACEUTICALS IN ownership

CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 9 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$12
-47.8%
105,0390.0%0.00%
Q2 2023$23
-17.9%
105,0390.0%0.00%
Q1 2023$28
+16.7%
105,039
+130.8%
0.00%
Q4 2022$2445,5200.00%
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Renaissance Technologies 21,572$17,0000.00%
Hudock, Inc. 300$00.00%
UBS Group AG 7,725$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 45,685$35,0000.00%
HRT FINANCIAL LP 10,870$8,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders